SARTORIUS STEDIM BIOTECH Value Stock - Dividend - Research Selection
Market price: 377,00 EUR
Sartorius Stedim Biotech S.A Fundamental data and company key figures of the share
|Annual reports in EUR|
|Net operating cash flow||416.879.000|
|Free cash flow||257.687.008|
|Liabilities & Shareholders equity||3.069.340.000|
|Diluted shares outstanding||92.177.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||42.147.639.296,00 USD|
|Indices||STOXX EUROPE 600,MSCI World Index|
|Sectors||Life Sciences Tools & Services|
|Raw Data Source||IFRS in Millionen EUR|
|Stock Split||2016-05-06,6.000000/1.000000; 2005-06-16,5.000000/1.000000; 2004-07-13,98163.000000/89239.000000; 2003-07-15,98163.000000/89239.000000; 2002-07-12,98163.000000/89239.000000; 2001-07-11,98163.000000/89239.000000; 1997-05-05,11.000000/10.000000; 1996-01-29,301.000000/292.000000|
Description of the company
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.